Alcohol Associated Liver Disease

Slide 1 · Alcohol-Associated

Liver Disease

Pathogenesis · morphology · clinicopathologic correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Connect alcohol metabolism to lipid accumulation and hepatocyte injury.

Recognize the morphologic spectrum from steatosis to cirrhosis.

Explain clinical presentation, laboratory patterns, and important diagnostic pitfalls.

Slide 3 · Three overlapping patterns of liver injury

Steatosis

Steatohepatitis

Fibrosis → cirrhosis

These patterns may coexist; Progression is not obligatory or uniform.

Slide 4 · Spectrum is not an inevitable linear pathway

Hepatic steatosis is an early, often reversible response.

Only a subset develops inflammatory injury and progressive fibrosis.

Some patients first present with cirrhosis without a recognized preceding syndrome.

Slide 5 · Alcohol exposure: Dose is important, not sufficient

Short-term exposure

Even 80 g of ethanol over 1–several days may induce reversible steatosis.

Sustained high intake

Daily consumption around ≥80 g increases the risk of severe hepatic injury.

Long-duration exposure

About ≥160 g/day over 10–20 years is frequently associated with severe disease.

Variable outcome

The source reports cirrhosis in only ~10–15% of patients with alcohol use disorder.

Slide 6 · Susceptibility varies among drinkers

Ethanol exposure

Host susceptibility

Coexisting liver insults

Severity of disease

Consumption alone does not determine which individuals develop advanced scarring.

Slide 7 · Sex modifies susceptibility

The source describes higher dose-for-dose susceptibility in females.

Variation in ethanol pharmacokinetics and metabolism may contribute.

Estrogen-related responses to intestinal endotoxin are a proposed additional mechanism.

Slide 8 · The gut–liver axis provides a second insult

Increased gut endotoxin

Portal delivery to liver

Kupffer-cell CD14 / TLR4

Cytokines, chemokines

An inflammatory amplifier may operate alongside direct ethanol toxicity.

Slide 9 · Genetic susceptibility is multifactorial

Twin studies support a genetic component, confounded by environment.

Polymorphisms in alcohol-processing enzymes may influence exposure to metabolites.

Variation in inflammatory mediators may modify the response to injury.

Slide 10 · Low-activity ALDH variants alter ethanol tolerance

Ethanol oxidation

Alcohol dehydrogenase forms acetaldehyde.

ALDH activity

Low activity limits conversion of acetaldehyde to acetate.

Clinical response

Acetaldehyde accumulation causes flushing, nausea, and intolerance.

Slide 11 · Comorbid injury amplifies alcohol-related damage

Iron overload

A second injury source that may worsen the hepatic response.

Steatotic metabolic disease

Steatosis and steatohepatitis may reflect mixed mechanisms.

Hepatitis B and C

Concurrent viral injury can aggravate severity and scarring.

Clinical implication

Do not attribute every abnormal liver test to alcohol.

Slide 12 · MetALD acknowledges overlapping etiologies

A category of MASLD with increased alcohol intake.

The source gives alcohol thresholds of >140 g/week in females or >210 g/week in males.

Overlapping metabolic and alcohol-related injury complicates etiologic attribution.

Slide 13 · Hepatocyte ethanol metabolism generates reducing equivalents

Ethanol → acetaldehyde

Acetaldehyde → acetate

NAD⁺ reduced to NADH

Hepatic redox shift

Alcohol dehydrogenase and aldehyde dehydrogenase increase the hepatic NADH burden.

Slide 14 · An altered NADH/NAD⁺ balance favors fat storage

High NADH

Alcohol oxidation shifts the hepatic redox state.

Fatty-acid oxidation

β-oxidation is suppressed, reducing lipid disposal.

Lipid accumulation

Triglyceride stores expand in hepatocytes.

Slide 15 · Suppression of fatty-acid oxidation promotes steatosis

Alcohol-induced redox changes reduce fatty-acid oxidation.

Less oxidative disposal leaves more fatty-acid substrate available.

Excess substrate contributes to intracellular triglyceride droplets.

Slide 16 · De novo lipid synthesis is also increased

Ethanol metabolism

Redox and enzyme changes

Fatty-acid synthesis ↑

Triglyceride accumulation

The source identifies increased expression of lipogenic enzymes as another route to steatosis.

Slide 17 · Impaired lipid export adds to steatosis

Hepatocellular lipid

Triglycerides require lipoprotein packaging for export.

Alcohol-associated dysfunction

Lipoprotein assembly and secretion may be impaired.

Net effect

Retention of lipids exacerbates hepatic fatty change.

Slide 18 · Peripheral lipid flux can augment hepatic lipid uptake

Peripheral fat catabolism

Circulating lipid pool ↑

Hepatocyte uptake ↑

Steatosis

The liver receives lipids in addition to those synthesized internally.

Slide 19 · Several metabolic effects converge on steatosis

Oxidation

Fatty-acid β-oxidation decreases.

Synthesis

Fatty-acid synthetic pathways are increased.

Export

Lipoprotein assembly/secretion may be impaired.

Delivery

Peripheral lipid mobilization increases substrates.

Slide 20 · Acetaldehyde directly injures hepatic structures

Acetaldehyde generation

Alcohol dehydrogenase forms a reactive aldehyde.

Protein adduct formation

Binding to proteins alters their function and may create neoantigens.

Structural injury

Cytoskeletal and membrane disturbances follow.

Slide 21 · Lipid peroxidation propagates injury

Acetaldehyde is associated with lipid-peroxidation reactions.

Membrane lipids undergo oxidative damage, disturbing integrity.

Protein injury and membrane dysfunction add to hepatocellular stress.

Slide 22 · CYP2E1 induction increases toxic oxidative products

Heavy alcohol exposure

Microsomal CYP2E1 becomes induced.

Oxidation of ethanol

The pathway generates reactive oxygen species (ROS).

Cellular damage

ROS injure proteins, membranes, and mitochondria.

Slide 23 · Mitochondrial dysfunction adds to cell death

Oxidative stress

Mitochondrial injury

Hepatocyte dysfunction

Apoptosis / injury

Mitochondria are important targets of oxidant injury in affected hepatocytes.

Slide 24 · Glutathione depletion reduces antioxidant defenses

Alcohol exposure

Methionine metabolism becomes impaired.

Glutathione ↓

Antioxidant capacity is reduced.

Oxidative susceptibility ↑

ROS-mediated hepatocyte injury becomes more likely.

Slide 25 · Homocysteine can trigger ER stress

Altered methionine pathways

Homocysteine ↑

Endoplasmic reticulum stress

Hepatocyte dysfunction

A distinct stress mechanism complements oxidant injury.

Slide 26 · Alcohol induction can change drug hepatotoxicity

Alcohol-induced microsomal enzymes may accelerate formation of toxic drug metabolites.

The textbook uses acetaminophen as an example.

Drug exposure and alcohol history should be considered together in a liver-injury assessment.

Slide 27 · Intestinal products amplify hepatic inflammation

Intestinal barrier

Alcohol-related permeability permits greater endotoxin passage.

Portal delivery

Bacterial components reach Kupffer cells.

Innate immune activation

Inflammatory cytokines and chemokines are released.

Slide 28 · CD14 and TLR4 link endotoxin to Kupffer cells

LPS from intestine

CD14 on Kupffer cells

TLR4 signaling

Inflammatory mediators

This pathway is proposed in the source as one modifier of inflammatory disease.

Slide 29 · PAMPs and DAMPs arise from different sources

Pathogen-associated molecules

Damage-associated molecules

Microbial endotoxin arrives from the gut.

These signals reflect intestinal-derived products.

Dying hepatocytes release intracellular signals.

These signals reflect local tissue damage.

Slide 30 · Inflammasome activation amplifies liver inflammation

PAMPs + DAMPs

Inflammasome activation

Caspase-1 / IL-1β

Inflammatory injury

Increased hepatic IL-1β and caspase-1 in alcohol-associated disease.

Slide 31 · A multifactorial injury model

Metabolic perturbation

Steatosis results from altered lipid synthesis, oxidation, export, and supply.

Chemical toxicity

Acetaldehyde and reactive oxygen species injure cellular constituents.

Innate immunity

Gut-derived and hepatocyte-derived signals sustain inflammation.

Tissue repair

Repeated injury elicits fibrosis and architectural distortion.

Slide 32 · Why zone 3 is a typical starting point

Portal tract

Central vein

Zone 1

Zone 2

Zone 3

Sinusoidal blood flow: Portal/periportal → centrilobular

Alcohol-associated lesions characteristically begin in zone 3.

Slide 33 · Morphologic sequence: Injury begins centrally

Typical changes begin in the centrilobular region (acinar zone 3).

With greater injury, abnormality may extend toward portal tracts.

This zonal pattern helps organize interpretation of steatosis and fibrosis.

Slide 34 · Steatotic hepatocytes accumulate lipid vacuoles

Schematic: Simplified hepatocytes, not a diagnostic histology image

Droplets may enlarge and coalesce, displacing nuclei to the cell margin.

Slide 35 · Macrovesicular steatosis is predominant

Macrovesicular pattern

Microvesicular pattern

Large fat vacuoles distend hepatocytes.

The nucleus is often displaced to the side.

Smaller droplets occupy cytoplasm.

This is not the predominant pattern in typical disease.

Slide 36 · Gross fatty liver: Enlarged, yellow, greasy

The source describes a soft, yellow, greasy organ with marked enlargement.

Chronic severe steatosis may produce a very heavy liver.

Gross appearance expresses widespread hepatocellular triglyceride accumulation.

Slide 37 · Alcoholic foamy degeneration is an atypical pattern

A relatively uncommon steatotic pattern can occur with prolonged heavy exposure.

Diffuse small-droplet macrovesicular to microvesicular change may be seen.

Endoplasmic reticulum and mitochondrial injury are implicated in the source.

Slide 38 · Steatosis can reverse with abstinence

Ethanol exposure withdrawn

Hepatic fat accumulation may resolve

Simple fatty change generally permits substantial reversal when the injurious exposure stops.

Slide 39 · Ballooning signals significant hepatocyte injury

Schematic: Simplified hepatocytes, not a diagnostic histology image

Swollen hepatocytes have pale cytoplasm and disrupted cytoskeletal organization.

Slide 40 · Mallory hyaline is an abnormal protein aggregate

Cytoskeletal injury

Keratin intermediate filaments are damaged.

Incomplete clearance

Altered keratins accumulate with ubiquitin.

Mallory hyaline

Eosinophilic cytoplasmic aggregates may become conspicuous.

Slide 41 · Keratin 8/18 highlight cytoskeletal alterations

Mallory hyaline contains partially degraded, ubiquitinated keratin filaments.

Keratins 8 and 18 may be demonstrated immunohistochemically.

The staining pattern illustrates cytoskeletal collapse in injured ballooned cells.

Slide 42 · Neutrophils may cluster around injured hepatocytes

Neutrophils are commonly prominent in alcohol-associated hepatitis.

They may surround ballooned cells, especially with Mallory hyaline.

This distribution provides a useful morphologic clue, not a standalone diagnosis.

Slide 43 · Inflammation involves several immune populations

Neutrophils

Often conspicuous around affected hepatocytes.

Lymphocytes

Lobular infiltrates are common; Portal lymphocytes may appear.

Macrophages

Can increase in both lobules and portal tracts.

Hepatocyte death

Spotty necrosis/apoptosis is usual; Confluent injury can occur.

Slide 44 · Ballooning and Mallory hyaline are not equivalent

Ballooning

Mallory hyaline

An essential morphologic feature of steatohepatitis.

May be present without Mallory hyaline.

A cytoplasmic inclusion in some injured cells.

Not specific to alcohol-associated disease.

Slide 45 · Pericellular fibrosis begins in zone 3

Perisinusoidal collagen forms a network around hepatocytes

Schematic — not a diagnostic tissue image

Slide 46 · “Chicken-wire” fibrosis describes a network of scar

Early perisinusoidal/pericellular fibrosis surrounds groups of hepatocytes.

The resulting fine lattice produces a “chicken-wire” appearance.

Collagen stains help demonstrate this matrix pattern.

Slide 47 · Progressive scarring extends beyond zone 3

Zone 3 pericellular scar

Portal / periportal fibrosis

Bridging fibrosis

Cirrhosis

The original distribution expands with repeated, persistent injury.

Slide 48 · Bridging fibrosis interrupts the lobular framework

Fibrous septum

Parenchymal groups are separated by broad scar

Schematic — not a diagnostic tissue image

Slide 49 · Micronodular cirrhosis is a classic late pattern

Fibrous septa enclose regenerative parenchymal nodules

Slide 50 · Cirrhosis also changes hepatic vascular structure

Perivenular injury

Fibrosis develops around terminal venules.

Vascular remodeling

Phlebosclerosis and veno-occlusive lesions may occur.

Functional effect

Distorted perfusion compounds parenchymal dysfunction.

Slide 51 · “Burned-out” cirrhosis can lose obvious steatosis

A cirrhotic liver need not retain fatty droplets or active steatohepatitis.

Advanced scarring may dominate the biopsy or gross appearance.

A negative steatosis finding does not exclude alcohol as an earlier cause.

Slide 52 · Reversibility depends on the stage of disease

Steatosis

Typically reversible with cessation of alcohol exposure.

Early fibrosis

Some scar regression can occur after abstinence.

Established cirrhosis

Full restitution is less likely owing to structural and vascular alterations.

Rare exception

Complete regression of cirrhosis has been reported but is unusual.

Slide 53 · Clinical features of simple steatosis

Hepatomegaly may be the principal manifestation.

Serum bilirubin and alkaline phosphatase can be mildly increased.

Severe hepatocellular functional impairment is uncommon in isolated steatosis.

Slide 54 · Alcohol-associated hepatitis often appears acutely

An episode frequently follows a period of heavy drinking.

Patients may have malaise, anorexia, weight loss, and upper abdominal discomfort.

Tender hepatomegaly is a common examination finding.

The syndrome may coexist with previously established cirrhosis.

Slide 55 · Characteristic biochemical and hematologic findings

Bilirubin

Hyperbilirubinemia is common in clinically apparent hepatitis.

Transaminases

Serum AST and ALT increase.

Cholestasis markers

Alkaline phosphatase may be elevated.

Peripheral blood

Neutrophilic leukocytosis is often present.

Slide 56 · AST tends to exceed ALT in alcohol-associated injury

AST : ALT ≥ 2 : 1

This pattern as a useful clue, especially when alcohol exposure is not disclosed; It is not by itself diagnostic.

Slide 57 · The clinical presentation can mimic other disorders

Cholestatic presentation

Severe hepatitic presentation

An acute cholestatic syndrome can resemble extrahepatic obstruction.

Differential assessment remains necessary.

Advanced injury may resemble acute liver failure.

Severity is not determined from the AST:ALT ratio alone.

Slide 58 · Episodes of hepatitis have variable outcomes

Resolution can follow total abstinence and adequate nutrition.

Inflammation may persist even after exposure stops.

Repeated episodes can lead to fibrosis and cirrhosis.

The severity of any one episode is unpredictable.

Slide 59 · Cirrhosis adds hepatic synthetic dysfunction

Albumin / globulins

Abnormalities reflect altered hepatic synthetic capacity.

Coagulation proteins

Reduced clotting-factor synthesis contributes to coagulopathy.

Bilirubin

Hyperbilirubinemia may reflect advanced dysfunction.

Blood counts

Anemia may accompany advanced liver disease.

Slide 60 · Cirrhosis can remain clinically silent

Advanced architectural injury may precede a dramatic clinical presentation.

Infection, trauma, or another stressor can precipitate decompensation.

Diagnosis may therefore be delayed until complications appear.

Slide 61 · Alternative causes should still be investigated

A history of heavy drinking does not eliminate other liver etiologies.

In a subset of presumed alcohol-associated cirrhosis, another disease is identified.

Biopsy may help resolve uncertainty in selected patients.

Interpret histology together with clinical history and competing risk factors.

Slide 62 · The pathologic consequences of cirrhosis are systemic

Fibrotic distortion

Portal flow resistance ↑

Portal hypertension

Multiorgan consequences

Loss of functional parenchyma accompanies circulatory remodeling.

Slide 63 · Major complications drive late mortality

Hepatic failure

Encephalopathy or hepatic coma.

Portal hypertension

Severe gastrointestinal hemorrhage.

Systemic complications

Infection and hepatorenal syndrome.

Cancer risk

Hepatocellular carcinoma may develop in a cirrhotic liver.

Slide 64 · Cirrhosis increases hepatocellular carcinoma risk

Alcohol-associated cirrhosis provides a chronically injured, regenerative environment.

The source reports an annual HCC risk of 1%–6% in cirrhosis.

This is a textbook-era estimate, not an individualized risk prediction.

Slide 65 · Abstinence is the principal modifiable determinant

Stopping ethanol exposure permits resolution of many early morphologic changes.

Adequate nutrition is an important supportive component of recovery.

Established scarring and perfusion abnormalities may limit reversibility.

Continuing exposure increases the risk of recurrent injury.

Slide 66 · Compare three major clinicopathologic patterns

Feature

Steatosis

Steatohepatitis

Dominant lesion

Intracellular lipid droplets

Ballooning, inflammation ± Mallory hyaline

Early anatomic focus

Often centrilobular

Often zone 3 with lobular injury

Typical clinical expression

Hepatomegaly; minimal dysfunction

Acute illness, jaundice, inflammatory laboratory findings

Reversibility

Usually with abstinence

Variable; persistent disease can progress

Slide 67 · Cirrhosis: Fibrosis and architectural distortion

Question

Pathology-based answer

Characteristic morphology

Fibrous septa surround nodules; often initially micronodular.

Residual fat required?

No: advanced “burned-out” cirrhosis may lack steatosis.

Functional problem

Loss of parenchyma plus altered vascular perfusion.

Recovery after abstinence

Improvement possible, complete regression uncommon.

Slide 68 · Steatohepatitis has overlapping etiologies

Alcohol-associated

Metabolic dysfunction–associated

More conspicuous neutrophils may favor alcohol-associated injury.

Exposure history and distribution help interpretation.

Ballooning and Mallory hyaline may also occur.

Histologic findings overlap; No isolated lesion proves cause.

Slide 69 · Case 1: Enlarged fatty liver

A patient with heavy ethanol exposure has an enlarged liver. Microscopy shows predominantly large intracellular lipid vacuoles, with little inflammation or fibrosis. What process predominates?

Interpretation

Alcohol-associated steatosis. In the absence of major inflammation or established scarring, cessation of exposure can permit substantial reversal.

Slide 70 · Case 2: Ballooned cells and neutrophils

A patient develops jaundice after heavy drinking. Biopsy shows ballooned hepatocytes, Mallory hyaline, neutrophil-rich lobular inflammation, and pericellular fibrosis. How should the lesion be classified?

Interpretation

Alcohol-associated steatohepatitis is strongly supported by the combined exposure, clinical syndrome, and morphology. Individual features are not wholly specific.

Slide 71 · Case 3: Scar without residual fatty change

A nodular cirrhotic liver shows broad fibrous septa and altered vascular architecture but no obvious hepatocyte steatosis. Does the lack of fat exclude previous alcohol-associated injury?

Interpretation

No. Advanced “burned-out” cirrhosis may lack fat or active inflammation. Etiologic assignment requires clinical and exclusionary evidence.

Slide 72 · Synthesis: Dose, susceptibility, injury and scarring

Exposure + modifiers

Metabolic / oxidative stress

Inflammatory damage

Fibrosis and cirrhosis

Morphology and clinical disease arise from interacting rather than isolated mechanisms.

Slide 73 · Textbook reference and morphologic figures

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026), Chapter 18, pp. 766–769.

Fig. 18.18: relation among steatosis, steatohepatitis, and cirrhosis.

Figs. 18.19–18.21: steatosis and fibrosis, hepatocyte ballooning, and cirrhosis.